FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108586840> ?p ?o ?g. }

• W2108586840 endingPage "3148" @default.
• W2108586840 startingPage "3141" @default.
• W2108586840 abstract "In the normal kidney, rapamycin is considered to be non-nephrotoxic. In the present study, we investigated whether rapamycin is indeed non-nephrotoxic by examining the ultrastructural and molecular alterations of podocytes in healthy mice.Balb/c mice were given three different intraperitoneal doses of rapamycin for 1 week (dose model)-low-dose group: 1 mg/kg/day, intermediate-dose (ID) group: 1.5 mg/kg/day and high-dose (HD) group: 3 mg/kg/day; four mice in each group. An ID of rapamycin was also given for three different periods (time model): 1, 4 and 8 weeks; four mice were in each group. Mice treated with dimethyl sulphoxide served as controls. Body weight was measured weekly. Renal function was assessed by serum creatinine at the time of sacrifice. For estimation of albuminuria, 24-h urine collections were performed before treatment and weekly thereafter. Glomerular content of nephrin, podocin, Akt and Ser473-phospho-Akt was estimated by western blot and immunofluorescence. Nephrin and podocin messenger RNA (mRNA) were measured by real-time polymerase chain reaction. Mean podocyte foot process width (FPW) was measured by electron microscopy.Urine albumin levels increased in the HD and 4-week groups. Renal function was modestly deteriorated in the HD group. The mean FPW increased in a dose-dependant manner at Week 1, further deteriorated at Week 4 and finally improved at Week 8. Nephrin and podocin mRNA levels showed a significant decrease at Week 1 and were restored at Week 4 and 8. Nephrin and podocin protein levels were reduced at Week 4 and recovered at Week 8. Ser473-phospho-Akt significantly increased in all rapamycin-treated groups.Rapamycin induced significant ultrastructural and molecular alterations in podocytes in association with albuminuria. These alterations happened early during treatment and they tended to improve over an 8-week treatment period." @default.
• W2108586840 created "2016-06-24" @default.
• W2108586840 creator A5009527379 @default.
• W2108586840 creator A5019354779 @default.
• W2108586840 creator A5033102772 @default.
• W2108586840 creator A5036747001 @default.
• W2108586840 creator A5045886472 @default.
• W2108586840 creator A5047742234 @default.
• W2108586840 creator A5055315327 @default.
• W2108586840 creator A5064535251 @default.
• W2108586840 creator A5074550424 @default.
• W2108586840 creator A5080352920 @default.
• W2108586840 creator A5081057482 @default.
• W2108586840 creator A5088152275 @default.
• W2108586840 creator A5088226708 @default.
• W2108586840 creator A5091515734 @default.
• W2108586840 date "2012-01-30" @default.
• W2108586840 modified "2023-09-27" @default.
• W2108586840 title "Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice" @default.
• W2108586840 cites W1494362161 @default.
• W2108586840 cites W1495582719 @default.
• W2108586840 cites W1968014386 @default.
• W2108586840 cites W1969510397 @default.
• W2108586840 cites W1977587396 @default.
• W2108586840 cites W1983698019 @default.
• W2108586840 cites W1983981801 @default.
• W2108586840 cites W1985131786 @default.
• W2108586840 cites W1986324148 @default.
• W2108586840 cites W1986477836 @default.
• W2108586840 cites W1999999605 @default.
• W2108586840 cites W2010956761 @default.
• W2108586840 cites W2026210867 @default.
• W2108586840 cites W2039586517 @default.
• W2108586840 cites W2041926434 @default.
• W2108586840 cites W2056739095 @default.
• W2108586840 cites W2056827159 @default.
• W2108586840 cites W2061166531 @default.
• W2108586840 cites W2064438414 @default.
• W2108586840 cites W2081065237 @default.
• W2108586840 cites W2084382826 @default.
• W2108586840 cites W2084889883 @default.
• W2108586840 cites W2087256338 @default.
• W2108586840 cites W2095166735 @default.
• W2108586840 cites W2098661610 @default.
• W2108586840 cites W2101291881 @default.
• W2108586840 cites W2109335217 @default.
• W2108586840 cites W2111820685 @default.
• W2108586840 cites W2117225624 @default.
• W2108586840 cites W2117279066 @default.
• W2108586840 cites W2120804252 @default.
• W2108586840 cites W2128877622 @default.
• W2108586840 cites W2129585918 @default.
• W2108586840 cites W2142288396 @default.
• W2108586840 cites W2143753684 @default.
• W2108586840 cites W2145337089 @default.
• W2108586840 cites W2151396528 @default.
• W2108586840 cites W2151906880 @default.
• W2108586840 cites W2156146280 @default.
• W2108586840 cites W2168209664 @default.
• W2108586840 cites W4238567307 @default.
• W2108586840 cites W4242774795 @default.
• W2108586840 cites W4251110963 @default.
• W2108586840 doi "https://doi.org/10.1093/ndt/gfr791" @default.
• W2108586840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22290989" @default.
• W2108586840 hasPublicationYear "2012" @default.
• W2108586840 type Work @default.
• W2108586840 sameAs 2108586840 @default.
• W2108586840 citedByCount "10" @default.
• W2108586840 countsByYear W21085868402013 @default.
• W2108586840 countsByYear W21085868402014 @default.
• W2108586840 countsByYear W21085868402016 @default.
• W2108586840 countsByYear W21085868402017 @default.
• W2108586840 countsByYear W21085868402018 @default.
• W2108586840 countsByYear W21085868402019 @default.
• W2108586840 countsByYear W21085868402023 @default.
• W2108586840 crossrefType "journal-article" @default.
• W2108586840 hasAuthorship W2108586840A5009527379 @default.
• W2108586840 hasAuthorship W2108586840A5019354779 @default.
• W2108586840 hasAuthorship W2108586840A5033102772 @default.
• W2108586840 hasAuthorship W2108586840A5036747001 @default.
• W2108586840 hasAuthorship W2108586840A5045886472 @default.
• W2108586840 hasAuthorship W2108586840A5047742234 @default.
• W2108586840 hasAuthorship W2108586840A5055315327 @default.
• W2108586840 hasAuthorship W2108586840A5064535251 @default.
• W2108586840 hasAuthorship W2108586840A5074550424 @default.
• W2108586840 hasAuthorship W2108586840A5080352920 @default.
• W2108586840 hasAuthorship W2108586840A5081057482 @default.
• W2108586840 hasAuthorship W2108586840A5088152275 @default.
• W2108586840 hasAuthorship W2108586840A5088226708 @default.
• W2108586840 hasAuthorship W2108586840A5091515734 @default.
• W2108586840 hasBestOaLocation W21085868401 @default.
• W2108586840 hasConcept C104317684 @default.
• W2108586840 hasConcept C126189478 @default.
• W2108586840 hasConcept C126322002 @default.
• W2108586840 hasConcept C134018914 @default.
• W2108586840 hasConcept C159641895 @default.
• W2108586840 hasConcept C2776415932 @default.
• W2108586840 hasConcept C2776855237 @default.

• next